Starts 11/12/2024 | Expires 11/12/2026
The Obesity and Weight Loss Certificate Program provides healthcare professionals with in-depth knowledge and practical tools to manage and treat obesity and its related health conditions. Through six comprehensive courses, participants will explore the pathophysiology of obesity, evidence-based nutritional strategies, endocrine disorders contributing to weight gain, pharmacotherapy, and interdisciplinary approaches to obesity management. The program also covers metabolic complications, including hypertension and dyslipidemia, equipping learners with the skills needed to deliver effective, patient-centered care.
Physician CreditThe American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing CreditProvider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.
ABOM CreditApplicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 6 Group Two CME credits toward the ABOM application requirement.
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.
Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.
The primary target audience includes Nurse Practitioners, Physician Assistants, and Pharmacists.The secondary target audience includes Endocrinologists and Primary Care Physicians.
Starts 9/3/2025 | Expires 9/3/2027Dyslipidemia is a major contributor to cardiovascular disease, yet many patients remain undermanaged due to evolving guidelines and care complexities. This program addresses these gaps, helping clinicians optimize lipid management and improve cardiovascular outcomes.
Starts 12/15/2025 | Expires12/15/2027Osteoporosis and osteopenia are chronic conditions that significantly increase the risk of fractures both in the United States and globally. Effective management requires healthcare professionals to understand bone metabolism and the physiological changes that contribute to bone loss.
The Kidney in Cardiometabolic Disease session presented at the AACE 2025 Annual Meeting highlights the critical role of kidney function in managing cardiometabolic disorders, such as diabetes, heart failure, and cardiovascular diseases, emphasizing the importance of integrated care approaches through a case-based interactive program format.
The session aims to deepen understanding of how renal dysfunction can influence the progression and management of cardiometabolic diseases, with an emphasis on:
• The pathophysiology of chronic kidney disease within the cardiometabolic spectrum, including age-related changes and mineral-bone disorders.• The impact of renal impairment on cardiovascular risk and metabolic control.• Strategies for early detection and management of renal complications in cardiometabolic patients, including risk assessment considerations for aging populations with declining renal function